melanoma

Merck, Bristol drugs show longer survival for deadly cancers
Yahoo/Reuters
Thu, 05/19/16 - 09:59 am
Merck
Bristol-Myers Squibb
cancer immunotherapy
lung cancer
melanoma
Opdivo
Keytruda
ASCO 2016
Keytruda: Merck’s New Blockbuster for Its Immuno-Oncology Franchise
Yahoo/Market Realist
Sun, 03/6/16 - 11:33 am
Keytruda
Merck
immuno-oncology
melanoma
non-small cell lung cancer
Pharma's Big New Cancer Drug May Be an Old Red Dye
Fortune
Fri, 02/26/16 - 03:21 pm
cancer
Provectus Biopharmaceuticals
melanoma
BMS' Opdivo evens the score in melanoma with two new FDA green lights
Fierce Pharma
Mon, 01/25/16 - 10:32 pm
Bristol-Myers Squibb
Opdivo
FDA
melanoma
Bristol-Myers' Opdivo Gets Nod for Melanoma From U.K. Regulator
Bloomberg
Thu, 01/21/16 - 07:52 pm
Bristol-Myers Squibb
Opdivo
melanoma
UK
NICE
Amgen wins quick EU approval for Imlygic, its first-in-class immuno-oncology drug
Fierce Pharma
Sun, 12/20/15 - 04:32 pm
Amgen
Europe
Imlygic
melanoma
‘I want what Jimmy Carter had’: Patients clamor for the president’s cancer drug
Stat
Fri, 12/18/15 - 08:59 am
Keytruda
melanoma
patients
Jimmy Carter
Array Biopharma melanoma drug succeeds in late-stage study
Yahoo/Reuters
Wed, 12/16/15 - 10:09 am
Array Biopharma
melanoma
binimetinib
Keytruda Is Top Therapy for Melanoma in US
Yahoo/Market Realist
Mon, 12/14/15 - 10:13 am
Keytruda
melanoma
Merck
FDA declines expanded approval for Bristol-Myers' Opdivo drug
Yahoo/Reuters
Fri, 11/27/15 - 05:48 pm
FDA
Bristol-Myers Squibb
Opdivo
melanoma
FDA approves expanded use of Bristol-Myers' skin cancer drug
Yahoo/Reuters
Tue, 11/24/15 - 01:52 pm
FDA
Bristol-Myers Squibb
melanoma
Opdivo
The FDA Approves Exelixis, Inc's New Cancer Drug
Motley Fool
Mon, 11/23/15 - 10:05 am
FDA
Exelixis
Cotellic
melanoma
Exelixis Announces Presentation of Positive Overall Survival Results for COTELLIC™ in Combination with Vemurafenib in Advanced BRAF V600 Mutation-Positive Melanoma at Society for Melanoma Research 2015 International Congress
Yahoo
Sun, 11/22/15 - 10:49 am
Exelixis
Cotellic
melanoma
Merck Announces Initial Results for KEYTRUDA® (pembrolizumab) with Novel Immunotherapy Combinations from Three Investigational Studies Presented at the Society for Melanoma Research International Congress
Yahoo
Sun, 11/22/15 - 10:48 am
Merck
Keytruda
melanoma
FDA approves Genentech's Cotellic as part of melanoma combo
BioPharma Dive
Wed, 11/11/15 - 09:28 pm
FDA
Genentech
Cotellic
melanoma
Zelboraf
Amgen's First-of-its-Kind Skin Cancer Drug Wins U.S. Approval
Bloomberg
Tue, 10/27/15 - 09:25 pm
Amgen
T-Vec
melanoma
Amgen's T-Vec inches toward EU approval for melanoma
Fierce Biotech
Fri, 10/23/15 - 11:06 am
Amgen
T-Vec
melanoma
Europe
Genentech, Exelixis score another PhIII success for cobimetinib
Fierce Biotech
Tue, 10/6/15 - 09:59 am
Genentech
Exelixis
Cobimetinib
melanoma
BRAF V600
Bristol-Myers Cancer Drug Combination to Cost $256,000 a Year
Bloomberg
Thu, 10/1/15 - 02:16 pm
Bristol-Myers Squibb
Opdivo
Yervoy
drug pricing
melanoma
skin cancer
Incyte Hits High On Cancer Drug Data, Buyout Talk
Investors.com
Fri, 09/11/15 - 05:56 pm
Incyte
M&A
epacadostat
Yervoy
melanoma
Bristol-Myers Squibb

Pages